Gene-Edited Stem Cells for Ischemic Vascular Disease: Current Advances and Future Perspectives
Open Access
- 2 July 2026
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 681
Abstract
Ischemic vascular diseases remain a leading cause of morbidity and mortality worldwide and are frequently associated with irreversible tissue damage. Although stem cell-based therapies have shown promise for vascular regeneration, their clinical translation has been limited by poor survival, insufficient engraftment, functional heterogeneity, and immune rejection. Recent advances in genome-editing technologies, including CRISPR/Cas9, base editing, and prime editing, have provided powerful tools for overcoming these limitations through precise genetic modification of stem cells. Gene editing can enhance angiogenic potential, improve resistance to ischemic stress, augment paracrine activity, promote endothelial maturation, and reduce immunogenicity. In this review, we outline the current genome-editing toolbox and its application to stem cell engineering for vascular regeneration in ischemic disease. We also examine emerging therapeutic concepts, universal donor cell platforms, and key issues in safety and ethics, with a focus on translational pathways. Taken together, advances at the interface of genome editing and stem cell biology are likely to accelerate the development of regenerative therapies that deliver more durable vascular repair in ischemic vascular disease.Keywords
This publication has 56 references indexed in Scilit:
- Culture‐acquired genetic variation in human pluripotent stem cells: Twenty years onBioEssays, 2024
- Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cellsAngiogenesis, 2024
- Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem CellsStem Cell Reviews and Reports, 2023
- Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart DiseaseStem Cell Reviews and Reports, 2021
- Cell-based therapies for the treatment of myocardial infarction: lessons from cardiac regeneration and repair mechanisms in non-human vertebratesHeart Failure Reviews, 2018
- Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K PathwaysStem Cells, 2017
- Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial InfarctionStem Cells Translational Medicine, 2017
- Concise Review: Genomic Instability in Human Stem Cells: Current Status and Future ChallengesStem Cells, 2014
- Development and Applications of CRISPR-Cas9 for Genome EngineeringCell, 2014
- CRISPR-Cas-Mediated Targeted Genome Editing in Human Cells2014